CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
76.41
-0.62 (-0.80%)
Aug 12, 2026, 3:50 PM EDT - Market open
CG Oncology Employees
CG Oncology had 142 employees as of December 31, 2025. The number of employees increased by 29 or 25.66% compared to the previous year.
Employees
142
Change (1Y)
29
Growth (1Y)
25.66%
Revenue / Employee
$43,859
Profits / Employee
-$1,580,106
Market Cap
6.77B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 142 | 29 | 25.66% |
| Dec 31, 2024 | 113 | 52 | 85.25% |
| Dec 31, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| PTC Therapeutics | 991 |
| Mirum Pharmaceuticals | 433 |
| TG Therapeutics | 399 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| Erasca | 103 |
CGON News
- 5 days ago - CG Oncology price target raised to $85 from $82 at Truist - TheFly
- 5 days ago - CG Oncology price target lowered to $79 from $81 at RBC Capital - TheFly
- 6 days ago - CG Oncology reports Q2 EPS (90c), consensus (64c) - TheFly
- 6 days ago - CG Oncology Earnings release: Q2 2026 - Filings
- 6 days ago - CG Oncology Quarterly report: Q2 2026 - Filings
- 6 days ago - CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 15 days ago - CG Oncology announces publication of BOND-003 results in The Lancet Oncology - TheFly
- 15 days ago - CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology - GlobeNewsWire